Summary & Overview
HCPCS J7110: Infusion, Dextran 75, 500 ml
HCPCS Level II code J7110 denotes the infusion of dextran 75 in a 500 ml volume, a plasma volume expander used in specific clinical circumstances such as volume resuscitation and management of hypovolemia. Nationally, accurate coding for J7110 matters for appropriate clinical reporting, coverage determination, and consistent reimbursement across acute and outpatient infusion settings. The code is relevant to hospitals, infusion centers, and acute care providers that administer intravenous therapeutic fluids.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context of dextran 75 infusion, standard sites of service, and the operational implications for billing and claims processing. The publication provides benchmarks where available, notes on payer coverage patterns and policy considerations, and references to related service-line coding considerations.
This summary is intended for national audiences including billing professionals, revenue cycle managers, and clinical administrators seeking clarity on service description, payer scope, and what to expect when billing for infusion of dextran 75, 500 ml. Data not available in the input will be indicated where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code J7110 represents infusion of dextran 75, 500 ml. This service is a therapeutic intravenous infusion of a plasma volume expander used in settings where dextran administration is clinically indicated.
-
Service type: Intravenous infusion therapy
-
Typical site of service: Hospital outpatient departments, infusion centers, and acute care settings where intravenous fluid and plasma expander administration are performed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of chronic venous insufficiency and documented severe hypoalbuminemia presents to an outpatient infusion center for volume expansion and to improve intravascular oncotic pressure. After nursing assessment and a provider order for dextran 75, a pharmacist or nurse verifies allergies and interactions, prepares J7110 (Infusion, dextran 75, 500 ml), and the infusion is administered via peripheral IV over the indicated time while monitoring vital signs and for signs of hypersensitivity. The typical workflow includes pre-infusion assessment, informed consent documentation for risks (including anaphylaxis and coagulopathy), baseline vitals and weight, IV placement, medication administration record (MAR) entry, ongoing monitoring during infusion, and post-infusion observation with documentation of volume infused and patient response. Billing uses HCPCS Level II code J7110 with appropriate modifier(s) to indicate site or special circumstances and is typically performed in an outpatient infusion center, hospital outpatient department, or skilled nursing/rehabilitation facility when indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard reporting) | Use when no additional modifier applies to the service. |